Pathogens causing bloodstream infection in implantable cardioverter defibrillator and cardiac resynchronization therapy and defibrillator patients
| Pathogens . | All (n = 58) . |
|---|---|
| Gram-negative bacteria, n (%) | 24 (41) |
| Coagulase-negative staphylococci, n (%) | 10 (17) |
| Staphylococcus aureus, n (%) | 8 (12) |
| Enterococcusspp., n (%) | 6 (10) |
| Streptococcus spp., n (%) | 5 (8.6) |
| Anaerobes, n (%) | 3 (6.9) |
| Others | 2 (3.4) |
| Pathogens . | All (n = 58) . |
|---|---|
| Gram-negative bacteria, n (%) | 24 (41) |
| Coagulase-negative staphylococci, n (%) | 10 (17) |
| Staphylococcus aureus, n (%) | 8 (12) |
| Enterococcusspp., n (%) | 6 (10) |
| Streptococcus spp., n (%) | 5 (8.6) |
| Anaerobes, n (%) | 3 (6.9) |
| Others | 2 (3.4) |
Note that 36 patients had a total of 47 BSI. In four BSI episodes, the blood cultures were positive for multiple pathogens.
Pathogens causing bloodstream infection in implantable cardioverter defibrillator and cardiac resynchronization therapy and defibrillator patients
| Pathogens . | All (n = 58) . |
|---|---|
| Gram-negative bacteria, n (%) | 24 (41) |
| Coagulase-negative staphylococci, n (%) | 10 (17) |
| Staphylococcus aureus, n (%) | 8 (12) |
| Enterococcusspp., n (%) | 6 (10) |
| Streptococcus spp., n (%) | 5 (8.6) |
| Anaerobes, n (%) | 3 (6.9) |
| Others | 2 (3.4) |
| Pathogens . | All (n = 58) . |
|---|---|
| Gram-negative bacteria, n (%) | 24 (41) |
| Coagulase-negative staphylococci, n (%) | 10 (17) |
| Staphylococcus aureus, n (%) | 8 (12) |
| Enterococcusspp., n (%) | 6 (10) |
| Streptococcus spp., n (%) | 5 (8.6) |
| Anaerobes, n (%) | 3 (6.9) |
| Others | 2 (3.4) |
Note that 36 patients had a total of 47 BSI. In four BSI episodes, the blood cultures were positive for multiple pathogens.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
